A Study of CIN-107 in Adults With Primary Aldosteronism

Clinical trial NCT04605549 · COMPLETED

Trial details

NCT number: NCT04605549
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Primary Aldosteronism Hyperaldosteronism

Start date: 2021-03-08
Primary completion: 2024-10-28
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.